Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Joseph Schappert, MD

Medical Director
Icon Central Laboratories, Inc.
Member of the Healthcare Council

Joseph Schappert, MD, is the Medical Director at ICON Laboratories, Inc. in New York. He is involved in innovative and state-of-art information technology, flow cytometric and molecular diagnostic solutions in support of clinical trials conducted worldwide. Previously, Dr. Schappert was the Vice Chair of Pathology and Laboratory Medicine at the Beth Israel Medical Center and St. Luke's Roosevelt Hospital Center. He has expertise in infectious disease testing, cardiac markers, coagulation testing, point of care testing, laboratory automation, and molecular diagnostics. Dr. Schappert has presented on these subjects at local, national, and international conferences. He has also worked extensively with major diagnostic companies. (This is me - Update Profile)


Employment History
2007 - present Medical Director
Icon Central Laboratories, Inc.
2002 - 2007 Vice Chair of Pathology and Laboratory Medicine
BETH ISRAEL MEDICAL CENTER INC
1998 - 2007 Vice Chair of Pathology and Laboratory Medicine
ST LUKE'S-ROOSEVELT HOSPITAL CENTER

GLG Study Groups with Joseph Schappert, MD(?)

View All Study Groups with Joseph Schappert, MD

GLG NewsSM Analyses by Joseph Schappert, MD(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Novel molecules and diagnostic tests | 02-19-2008
Analysis of: Kidney Cancer Drug Linked to Higher Rate of Heart Problems | www.washingtonpost.com
Author: Joseph Schappert, MD, Medical Director , Icon Central Laboratories, Inc.

Diagnostic tools are availible to identify these adverse effects at an early stage in their clinical development. These tools should mitigate the seriousness of these adverse events.

Microrganisms elude our control | 03-05-2007
Analysis of: Proof Nailed Down that Antibiotics Use Leads to Resistance | www.medpagetoday.com
Author: Joseph Schappert, MD, Medical Director , Icon Central Laboratories, Inc.

Our experience with antibiotics has consistently shown that resistance occurs within 3-5 years of their widespread utilization. Our more recent experience with antiviral agents has been similar. Without diminishing the important role that antimicrobials have played in our recent history, it has also...

The future of clinical laboratory diagnostics | 03-05-2007
Analysis of: GE to acquire Abbott's invitro and point of care diagnostics businesses | egems.gehealthcare.com
Author: Joseph Schappert, MD, Medical Director , Icon Central Laboratories, Inc.

The purchase of Abbott Diagnostics (ADD) by General Electric follows the purchase of Bayer Diagnostics and DPC by Siemens. It can be anticipated that GE will purchase a second diagnostics company. Since this is part of a restructuring of the diagnostics industry away from pharmaceutical companies to...

GLG InstituteSM Seminars with Joseph Schappert, MD(?)

 
Joseph Schappert, MD has not participated in any GLGi Seminars.
View all GLG InstituteSM Seminars in Healthcare

Request a project with Joseph Schappert, MD









Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-11-19T05:45:17.993